Tag: Amgen

Amgen considers Turkey as a regional biopharmaceutical hub

The increase experienced in the domestic industry with the incentives issued by the government in a program with the pharmaceutical industry among primary strategic products, drew the attention of top pharma players to Turkey.

Biosimilar ABP 980 obtained a positive opinion from CHMP

cancer treatment
Amgen and Allergan have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorisation of ABP 980, a biosimilar to Herceptin®.

Amgen will transfer technology for manufacturing of blinatumomab to Pharmstandard

Amgen and Pharmstandard announced the signing of an agreement on technology transfer, manufacturing and commercialization of blinatumomab in the Russian market